This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 114/7/681    most recent CIRCULATIONAHA.106.622514v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kawakami, A. Articles by Sacks, F. M. Search for Related Content PubMed PubMed Citation Articles by Kawakami, A. Articles by Sacks, F. M. Pubmed/NCBI databases Substance via MeSH Related Collections Lipid and lipoprotein metabolism Endothelium/vascular type/nitric oxide Pathophysiology Cell signalling/signal transduction

(Circulation. 2006;114:681-687.)
© 2006 American Heart Association, Inc.

Vascular Medicine

Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells

Akio Kawakami, MD; Masanori Aikawa, MD, PhD; Pilar Alcaide, PhD; Francis W. Luscinskas, PhD; Peter Libby, MD; Frank M. Sacks, MD

From the Department of Nutrition, Harvard School of Public Health (A.K., F.M.S.); Center for Excellence in Vascular Biology, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School (M.A., P.L., F.M.S.); and Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School (P.A., F.W.L.), Boston, Mass. Dr Kawakami is now affiliated with the Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Correspondence to Frank M. Sacks, MD, Nutrition Department, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115. E-mail fsacks{at}hsph.harvard.edu

Received March 9, 2006; revision received May 22, 2006; accepted June 7, 2006.

Background— Activation of vascular endothelial cells (ECs) plays an important role in atherogenesis and plaque instability. Lipoproteins containing apolipoprotein CIII (apoCIII) predict coronary heart disease (CHD). We recently reported that apoCIII has a proinflammatory effect on human monocytes. In this study, we looked for a direct effect of apoCIII on EC expression of adhesion molecules, leading to monocytic cell adhesion.

Methods and Results— Treatment of ECs with apoCIII or apoCIII-rich VLDL caused human monocytic THP-1 cells to adhere to them under static condition or under laminar sheer stress (1.0 dyne/cm²). ApoCIII increased EC expression of vascular cell adhesion molecule-1 (VCAM-1) protein and intercellular cell adhesion molecule-1 (ICAM-1) protein (4.9±1.5-fold and 1.4±0.5-fold versus control, respectively). Furthermore, apoCIII remarkably increased membrane-bound protein kinase C (PKC) ß in ECs, indicating activation. A selective inhibitor of PKCß prevented the rise in VCAM-1 and THP-1 cell adhesion to ECs. Moreover, exposure of ECs to apoCIII induced nuclear factor-B (NF-B) activation. PKCß inhibition abolished apoCIII-induced NF-B activation, and NF-B inhibition reduced expression of VCAM-1, each resulting in reduced THP-1 cell adhesion. ApoCIII-rich VLDL also activated PKCß and NF-B in ECs and increased expression of VCAM-1. Pretreatment of ApoCIII-rich VLDL with anti-apoCIII neutralizing antibody abolished its effect on PKCß activation.

Conclusions— Our findings provide the first evidence that apoCIII increases VCAM-1 and ICAM-1 expression in ECs by activating PKCß and NF-B, suggesting a novel mechanism for EC activation induced by dyslipidemia. Therefore, apoCIII-rich VLDL may contribute directly to atherogenesis by activating ECs and recruiting monocytes to them.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				J. D Furtado, H. Campos, L. J Appel, E. R Miller, N. Laranjo, V. J Carey, and F. M Sacks Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1623 - 1630. [Abstract] [Full Text] [PDF]

				R. R. S. Packard and P. Libby Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction Clin. Chem., January 1, 2008; 54(1): 24 - 38. [Abstract] [Full Text] [PDF]

				E. Galkina and K. Ley Vascular Adhesion Molecules in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2292 - 2301. [Abstract] [Full Text] [PDF]

				C. A. Gleissner, N. Leitinger, and K. Ley Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis Hypertension, August 1, 2007; 50(2): 276 - 283. [Full Text] [PDF]

				C. Zheng, C. Khoo, K. Ikewaki, and F. M. Sacks Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions J. Lipid Res., May 1, 2007; 48(5): 1190 - 1203. [Abstract] [Full Text] [PDF]

				P. Libby Fat Fuels the Flame: Triglyceride-Rich Lipoproteins and Arterial Inflammation Circ. Res., February 16, 2007; 100(3): 299 - 301. [Full Text] [PDF]

				A. Kawakami, M. Aikawa, N. Nitta, M. Yoshida, P. Libby, and F. M. Sacks Apolipoprotein CIII-Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin-Sensitive G Protein- and Protein Kinase C{alpha}-Mediated Nuclear Factor-{kappa}B Activation Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 219 - 225. [Abstract] [Full Text] [PDF]